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Abstract
OBJECTIVE: To evaluate the therapeutic effect of
scalp electroacupuncture for mild cognitive impair-
ment (MCI) in the early stage.
METHODS: Two hundred and thirty three MCI pa-
tients were randomly divided into three groups:
the drug group, the scalp electroacupuncture
group, and the syndrome differentiation group. For
the scalp electroacupuncture group, the points of
Baihui (DU 20), Sishecong (EX-HN1), Fengchi (GB
20), and Shenting (DU 24) were selected. For the
syndrome differentiation group, specific acupoints
were added on the basis of syndrome differentia-
tion and according to the scale for the differentia-
tion of syndromes in vascular dementia (SDSVD) be-
side the acupoints used in the scalp electroacu-
puncture group. For the drug group, nimodipine
was orally administered. Each patient was treated
for two courses, eight weeks. The score differences
in mini-mental state examination (MMSE), picture
recognition, and clock drawing test were observed
before and after the treatment.
RESULTS: After treatment, the score differences in
MMSE and clock drawing test were of obvious sta-
tistical significance among three groups (P<0.01,
P<0.05). The score differences in picture recogni-
tion were of extremely statistical significance be-
tween the scalp electroacupuncture group and
the syndrome differentiation group (P<0.01),
while the difference was not found in the drug
group (P>0.05). There were statistical significant
differences in therapeutic effects between the
scalp electroacupuncture group and the drug
group, and between the syndrome differentiation
group and the drug group (P<0.05), while no sta-
tistical difference was found between scalp elec-
troacupuncture group and the syndrome differen-
tiation group (P>0.05).
CONCLUSION: All the three therapies may improve
the cognitive function of MCI patients. The thera-
peutic effects in the scalp electroacupuncture and
syndrome differentiation groups were basically the
same, but superior to nimodipine.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Cognitive impairment is common among older people.
Mild cognitive impairment (MCI) is a frequently used
diagnostic concept, defined by objective cognitive im-
pairment in combination with subjective decline but
without dementia.1 MCI is a clinical status between
normal aging and mild dementia.2 MCI may be divid-
ed into three subtypes:3 amnestic MCI (aMCI), multi-
ple domains MCI and single non-memory MCI. MCI
has been associated with an increased risk of progres-
sion of Alzheimer's disease.4 Early studies appeared to
indicate that patients with MCI were at high risk of
further cognitive decline and progression to Alzheimer
dementia.5 Most clinical researches show that 44% of
the patients diagnosed as cognitive impairment turn in-
to Alzheimer's transit (AD) within 3 years in follow-up
studies at an annual average rate of 15%.6 According to
AD International, as many as 28 million of the world's
36 million people with dementia have yet to receive a
diagnosis, and therefore do not have access to treat-
ment, information, and care.7
The main clinical manifestations may include memory
impairment, ability damage in language, attention, vi-
sion and space, and the psychological behavior symp-
toms, such as apathy, depression, anxiety, agitation,
and irritability. Currently, it has been publicly known
as a transitional phase of dementia. This research dis-
plays the features of Traditional Chinese Medicine
(TCM) syndrome differentiation and carries out a
RCT study to evaluate the therapeutic effects of scalp
electroacupuncture for MCI. Acupuncture, a treatment
of TCM, remains promising as an investigational thera-
py to treat neurological diseases including chronic
pain, drug addiction, stroke as well as dementia.8-10
MATERIALS ANDMETHODS
Subjects
The 252 cases of MCI in this series were recruited
from the outpatient and inpatient departments of The
Affiliated Hospital of Chengdu University of Tradition-
al Chinese Medicine, People's Hospital of Sichuan
Province, and Chengdu Hospital of Integrated Chinese
and Western Medicine in the period of from August
2008 to January 2010. All the patients voluntarily par-
ticipated in this research and signed the informed con-
sent form. According to the inclusion and exclusion cri-
teria, the patients were randomly divided into the drug
group, the scalp electroacupuncture group and the
TCM syndrome differentiation group.
Inclusion criteria
1) The patients meeting the MCI diagnostic criteria,
mainly with memory impairment (amnestic MCI) con-
firmed by insiders, and had a history of the memory
impairment ≥ 3 months.11-13
2) Score in MMSE was 24-27.
3) Score in picture recognition was below the age-edu-
cation, matching 1.5SD.
4) Score in clinical dementia rating (CDR) was 0.5.
5) Global deterioration scale (GDS) was assessed as 2
to 3.
6) Hachinskilnchemic score (HIS) scale score ≤4.
7) Hamilton depression scale (HAMD) scores <8.
8) The patients aged 55 to 85 (men or women).
9) The patients had a certain level of education, with
an educational time longer than 1 year.
10) The patients voluntarily participated in the trial
and signed the informed consent.
Note: the patients who met all the above 10 items were
included.
Exclusion criteria
1) The patients had brain structure lesions which may
cause cognitive impairment, such as traumatic brain in-
jury and intracranial space-occupying lesions, or had
congenital mental retardation.
2) The patients were complicated by diabetes, serious
diseases of the cardiovascular, cerebrovascular, liver, kid-
ney and hematopoietic systems, mental illness, and
with visual and hearing impairments.
3) The patients had alcohol or drug dependency in the
past six months.
4) The patients were illiterate.
5) The patients were participating in other clinical tri-
als.
Note: the patients who met any one of the above 5
items were excluded.
Treatments
Medical drug and apparatus: Medical drug: nimodip-
ine (trade name: Nimotop, 30 mg/pill manufactured
by the Harbin Bole pharmaceutical company. Approval
number: 200432, Heilongjiang, China).
Acupuncture needles: Huatuo disposable needles pro-
duced by Suzhou Medical Products Factory Co., Ltd.
(0.30 × 25 mm and 0.30 × 40 mm)
Electro-acupuncture device: Xinsheng electroacupunc-
ture apparatus (G6805-II) produced in Qingdao.
Methods of treatment: 1) The scalp electroacupuncture
group: Baihui (DU 20), Sishencong (EX-HN1), Feng-
chi (GB 20) and Shenting (DU 24) were selected ac-
cording to our previous clinical practice for treating vas-
cular dementia.14 The patients were generally in seating
position. After sterilization, the needles were inserted
into the acupoints subgaleally along the scalp at an an-
gle of 15°-30°. Fengchi (GB 20) was punctured 1.7-
4.0 cm in the direction toward nose tip. Shenting
(DU 24), the anterior Sishencong (EX-HN1), and Bai-
hui (DU 20) were punctured forwards, and the left,
right and posterior Sishencong (EX-HN1) toward Bai-
hui (DU 20). The two acupoint groups were alternate-
ly used for electroacupuncture with continuous wave,
frequency 3-15 Hz, intensity 2-4 mA. The one group
47
JTCM |www. journaltcm. com February 15, 2013 |volume 33 | Issue 1 |
Zhang H et al. / Clinical Study
were Shenting (DU 24), Baihui (DU 20), and the left
& right Sishencong (EX-HN1). The other group were
the anterior & posterior Sishencong (EX-HN1), and
the left & right Fengchi (GB 20). The electroacupunc-
ture lasted 30 min each time, three times a week, total-
ly 24 sessions.
2) The syndrome differentiation group: TCM syn-
dromes were differentiated according to syndromes in
vascular dementia (SDSVD) written by Jinzhou Tian15
in 2000. Beside the acupoints used in scalp electroacu-
puncture group, one specific acupoint corresponding
to the highest score of the syndrome in SDSVD was
added. For the kidney essence deficiency syndrome,
Taixi (KI 3) was added. For the phlegm blocking me-
ridian syndrome, Fenglong (ST 40) was selected. For
the blood stasis blocking meridian syndrome, Xuehai
(SP 10) was added. For the liver-Yang hyperactivity syn-
drome, Taichong (LR 3) was added. For the Qi and
blood deficiency syndrome, Zusanli (ST 36) was add-
ed. Electroacupuncture was given the same as in the
scalp electroacupuncture group.
3) Drug group: nimodipine was orally administered
30 mg each time, 3 times a day, for eight weeks.
Index detected
Cognitive function: MMSE, picture recognition and
clock-drawing test were adopted to evaluate the pa-
tients' cognitive function, which included cognitive
evaluation (time, location, calculation), memory (in-
stant and short-term), speech (name, repeat, reading,
writing), and application & visual-spatial ability (appli-
cation and picture-copying).
Criteria for therapeutic effects: The criteria were estab-
lished in accordance with the relevant standards set by
the Age-delaying Committee of China Institute of Tra-
ditional Chinese Medicine, described in foreign ni-
modipine clinical efficacy criteria, and the Aricept Clin-
ical Efficacy Criteria by Shanghai Institute of Mental
Health. Improvements were assessed by efficacy index
(score change percentage) of MMSE, and picture recog-
nition. Markedly effective: efficacy index≥20%; Effec-
tive: 12% ≤efficacy index<20% ; Failed: 0≤efficacy in-
dex<12%; Deterioration: - 12%≤efficacy index<0.
Statistical analyses
SPSS 13.0 software was used to analyze the data. For
measurement data, normal test was performed firstly.
For the measurement data fitting normal distribution,
using t test, while for measurement data not fitting the
normal distribution, using non-parametric test. For
enumeration data, using χ2 test, and for Ranked data,
using the Wilcoxon rank sum test.
RESULTS
Baseline comparison
Among the three groups, no significant differences
were found in sex, age, education, CDR, and MMSE
score. Thus, the three groups were comparable with a
balanced baseline (P>0.05, Table 1 and Table 2).
Comparison of efficacy index
Table 3 showed that between scalp electroacupuncture
group, syndrome differentiation group and drug group,
the therapeutic effects were of statistical significance
(P<0.05), while no significant difference was found be-
tween the scalp electroacupuncture group and the syn-
drome differentiation group (P>0.05).
Comparison of scale scores after treatment
Table 4 showed that the score-differences in MMSE
and clock drawing test in the three groups before thera-
py and after therapy were of obvious statistical signifi-
cance (P<0.01, P<0.05). The score-differences before
therapy and after therapy in picture recognition in the
Table 1 Sex, age, dementia and cultural level, and the grouping situation
Group
Drug
Scalp
electroacupuncture
Syndrome
differentiation
n
75
80
78
Male/Female
37/38
39/41
33/45
Age
(year, xˉ ± s )
72±9
71±8
71±8
Clinical dementia
CDR=0
23
15
22
CDR=0.5
52
65
56
Degree of education
Primary
school
11
11
17
Middle
school
44
51
44
University
20
18
17
Note: CDR: clinical dementia rating.
Table 2 MMSE, picture recognition, clock drawing test scores, and the grouping situation before treatment ( xˉ ± s )
Drug
Scalp electroacupuncture
Syndrome differentiation
P value
n
75
80
78
-
MMSE
25.1±0.9
25.1±0.9
24.9±0.9
0.288
Picture recognition
10.8±2.8
10.1±3.1
10.7±2.7
0.292
Clock drawing test
1.0±2.1
0.9±1.5
0.7±1.3
0.452
Note: MMSE: mini-mental state examination.
48
JTCM |www. journaltcm. com February 15, 2013 |volume 33 | Issue 1 |
Zhang H et al. / Clinical Study
scalp electroacupuncture group and the syndrome dif-
ferentiation group were of extremely statistical signifi-
cance (P<0.01), while the difference was not found in
the drug group (P>0.05). The therapeutic effects be-
tween the scalp electroacupuncture group and the drug
group, and between the syndrome differentiation
group and the drug group were of statistical significant
difference (P<0.05), while no statistical significance
was found between the scalp electroacupuncture group
and the syndrome differentiation group (P>0.05).
DISCUSSION
There is no the term of mild cognitive impairment
(MCI) in TCM. MCI can be classified into amnesia
and forgetfulness according to the clinical manifesta-
tions. Based on the researches reported in literatures of
MCI, it can be concluded that the focus of MCI is in
the brain. The basic pathogenesis in TCM is deficiency
in origin and excess in superficiality. Deficiency in ori-
gin is manifested by kidney deficiency, and Qi and
blood deficiency, while the excess in superficiality is
manifested by phlegm, blood stasis and hyperactivity
of liver Yang.
In the treatment, Baihui (DU 20), Sishencong
(EX-HN1), Fengchi (GB 20) and Shenting (DU 24)
are selected on the basis of our previous study14 for
treating vascular dementia. For the syndrome of kidney
deficiency, Taixi (KI 3) is added.For the syndrome of
turbid phlegm blocking the collaterals, Fenglong (ST
40) is added. As the Luo-Connecting Points of Stom-
ach Meridian of Foot-Yangming, it connects with the
Spleen Meridian of Foot-Taiyin, thus Stomach and
Spleen Meridian have a closer connection. For the syn-
drome of Liver-Yang hyperactivity, Taichong (LV 3) is
added. For the syndrome of blood stasis blocking the
collaterals, Xuehai (SP 10) is added. For the syndrome
of Qi and blood deficiency, Zusanli (ST 36), is added.
The stomach and spleen are interior-exteriorly related,
and they are both the barn organs, that is, the source
for the acquired constitution and also for the Qi and
blood. Nimodipine is used in the control group.
The results of the present study show that all the three
therapies can improve the cognitive function of MCI
patients; and that the therapeutic effects in the scalp
electroacupuncture group and the syndrome differenti-
ation group are basically the same, but obviously better
than that in the nimodipine group. Because of shortage
Table 3 Comparison of the curative effect after treatment
Scale
MMSE
Picture
recognition
Group
Drug
Scalp electroacupuncturea
Syndrome differentiationa
Drug
Scalp electroacupuncturea
Syndrome differentiationa
n
75
80
78
75
80
78
Number of cases
Markedly
effective
1
13
17
15
44
51
Effective
36
39
40
10
15
8
Failed
37
27
21
24
15
13
Deterioration
1
1
0
26
6
6
P value
0.000
0.000
Notes: MMSE: mini-mental state examination. Compared with the drug group, aP<0.05.
Table 4 Comparison of scale scores after treatment ( xˉ ± s )
Scale
MMSE
Picture recognition
Clock drawing test
Before treatment
After treatment
P valuea
Before treatment
After treatment
P valuea
Before treatment
P valuea
Drug (n=75)
25.1±0.9
27.4±1.4
0.000
10.8±2.8
10.6±3.0
0.701
1.0±2.1
0.018
Scalp electroacupuncture
(n=80)
25.1±0.9
28.4±1.4b
0.000
10.1±3.1
12.5±3.1b
0.000
0.9±1.5
0.000
Syndrome
differentiation
(n=78)
24.9±0.9
28.5±1.3b
0.000
10.7±2.7
13.3±2.7b
0.000
0.7±1.3
0.001
P value
0.29
0
0.2
0
0.45
Notes: ameans the comparison of scale scores before and after the a treatment; bP<0.05, compared with the drug group; cmeans the
comparison among groups.
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of funds for the research, the syndrome diagnoses and
the points used are based on the TCM differentiation
scale. As a result, the patients are diagnosed as having
only one syndrome. In fact, most of them actually have
more than one syndrome, and the patients with a same
syndrome may show different physical conditions. In
this study, we don't use any other points for the pa-
tients with complicated severer conditions, which may
be the reason why the therapeutic effects in the scalp
electro-acupuncture group and the syndrome differenti-
ation group are the same. All the problems should be
improved in future studies.
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